PubMed Health treatment related to Herpes Zoster: 62
Pain and fever can be relieved with medication such as acetaminophen (paracetamol) or acetylsalicylic acid (the drug in medicines like Aspirin ). Prescription painkillers are sometimes used to relieve more severe pain. Thorough skin care is recommended if you have shingles . Antiseptic or anti-itch lotions, gels and powders are often used to relieve the itching and dry out the blisters . Most of them contain tanins, zinc , menthol or polidocanol . If blisters have already formed, people are sometimes advised to use cooling wraps. But there’s no good scientific research on how well these treatments work. Drugs that fight viruses can be used in people who are over 50 or have a weakened immune system , if the condition is very severe, affects the head and neck area, or there is a higher risk of complications. This is known as "antiviral therapy ." Using antiviral medication early on can help speed up recovery and make the pain go away faster. So people are advised to start antiviral therapy no later than 72 hours after the rash starts. In severe cases the medicine can also be given through a drip into a vein (intravenous infusion ). If the ear is affected, steroids are often used too. But it still isn’t clear what pros and cons this kind of combination therapy may have.
Drugs for Herpes Zoster (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 227)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Foscarnet |
Approved |
Phase 4 |
|
4428-95-9, 63585-09-1 |
3415 |
Synonyms:
1nki
34156-56-4
4428-95-9
4428-95-9 (Parent)
63585-09-1
63585-09-1 (tri-hydrochloride salt)
79510_FLUKA
A 29622
A-29622
AC1L1FVT
AC1L2C37
AC1L5400
AC1NB82R
AC1Q1UNV
AC-2085
Ambap63585-09-1
AR-1L5079
BSPBio_003067
C06456
Carboxyphosphonate
Carboxyphosphonic acid
CHEBI:127780
CHEBI:141644
CHEBI:60269
CHEMBL666
CHEMBL754
CID169569
CID3415
CID44561
D00579
D02267
DB00529
dihydroxyphosphanecarboxylic acid oxide
Dihydroxyphosphinecarboxylic acid oxide
Dihydroxyphosphinecarboxylic acid oxide and MSL, neutralizing monoclonal antibody
Dihydroxyphosphinecarboxylic acid oxide trisodium salt
Dihydroxyphosphinecarboxylic acid oxide trisodium salt hexahydrate
Disodium salt, foscarnet
DivK1c_000915
DRG-0017
EHB 776
EHB-776
Formic acid, phosphono-, trisodium salt, hexahydrate
Forscarnet sodium
Foscarmet
foscarnet
Foscarnet & IFN-.ALPHA.
Foscarnet barium (2:3) salt
Foscarnet calcium (2:3) salt
Foscarnet disodium salt
Foscarnet magnesium (2:3) salt
Foscarnet manganese (2+) (2:3) salt
Foscarnet sodico
Foscarnet sodico [Spanish]
Foscarnet sodique
Foscarnet sodique [French]
Foscarnet sodique [INN-French]
Foscarnet sodium
FOSCARNET SODIUM
Foscarnet sodium (USAN/INN)
Foscarnet sodium [USAN:INN:BAN]
foscarnet sodium hexahydrate
Foscarnet sodium hexahydrate
Foscarnet sodium hydrate
Foscarnet sodium hydrate (JAN)
Foscarnet trilithium salt
Foscarnet tripotassium salt
Foscarnet trisodium salt
Foscarneto sodico
Foscarneto sodico [INN-Spanish]
Foscarnetum natricum
Foscarnetum natricum [INN-Latin]
Foscarnetum natricum [Latin]
Foscavir
|
Foscavir (TN)
Hexahydrate, foscarnet sodium
HMS1921D18
HMS2092N15
HMS502N17
HS-0008
IDI1_000915
KBio1_000915
KBio2_001839
KBio2_004407
KBio2_006975
KBio3_002567
KBioGR_001419
KBioSS_001839
LS-105952
LS-105953
LS-183979
LS-187063
LS-187793
MolPort-003-665-560
MolPort-003-895-968
MSL & PFA
NCGC00094941-01
NCGC00094941-02
NChemBio.2007.9-comp7
NINDS_000915
NSC313410
P6801_ALDRICH
P6801_SIGMA
PFA & rIFN.alpha.A
Phgosphonocarboxylic acid
Phosphinecarboxylic acid, dihydroxy-, oxide
Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt
Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt, hexahydrate
Phosphonoformate
Phosphonoformate(trisodium) & Recombinant Alpha-A Interferon
Phosphonoformate, trisodium
Phosphonoformic acid
Phosphonoformic acid & IFN-.ALPHA.
Phosphonoformic acid trisodium salt hexahydrate
Phosphonoformic acid, trisodium salt
Phosphonoformic acid, trisodium salt, hexahydrate
Phosphonomethanoate
phosphonomethanoic acid
Phosphonomethanoic acid
Prestwick_1024
sodium dioxidophosphanecarboxylate oxide hydrate(3:1:6)
Sodium hexahydrate, foscarnet
Sodium phosphonoformate tribasic hexahydrate
Sodium, foscarnet
SPBio_000735
Spectrum_001359
SPECTRUM1502019
Spectrum2_000668
Spectrum3_001484
Spectrum4_000840
Spectrum5_000932
Triapten
Trilithium salt, foscarnet
Tripotassium salt, foscarnet
Trisodium carboxyphosphate
trisodium carboxyphosphate (anhydrous)
trisodium dioxidophosphanecarboxylate oxide
trisodium dioxidophosphinecarboxylate oxide
trisodium phosphonatoformate
trisodium phosphonatoformate hexahydrate
Trisodium phosphonoformate
trisodium phosphonoformate (anhydrous)
Trisodium phosphonoformate hexahydrate
Trisodium phosphonoformte hexahydrate
Trisodium salt, foscarnet
UNII-364P9RVW4X
UNII-964YS0OOG1
Virudin
|
|
2 |
|
Capsaicin |
Approved |
Phase 4 |
|
404-86-4 |
1548943 |
Synonyms:
(6E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
(6E)-N-{[4-hydroxy-3-(methyloxy)phenyl]methyl}-8-methylnon-6-enamide
(e)8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide
(E)-8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide(8CL)
(E)-Capsaicin
(E)-N-((4-Hydroxy-3-methoxyphenyl)-methyl)-8-methyl-6-nonenamide
(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide
[(E)-N-(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
12084_FLUKA
21748_FLUKA
21748_SIGMA
21750_FLUKA
21750_SIGMA
360376_ALDRICH
360376_SIGMA
404-86-4
6-Nonenamide, (E)-N-((4-hydroxy-3-methoxy-phenyl)methyl)-8-methyl
6-Nonenamide, 8-methyl-N-vanillyl-, (E)- (8CI)
8 Methyl N vanillyl 6 nonenamide
8 Methyl N Vanillyl 6 Nonenamide
8-Methyl-N-vanillyl-6-nonenamide
8-Methyl-N-Vanillyl-6-Nonenamide
8-Methyl-N-vanillyl-trans-6-nonenamide
912457-62-6
AC1LU7K3
AC1Q46B3
Alacan brand OF capsaicin
Alacan Brand of Capsaicin
Antiphlogistine rub a-535 capsaicin
Antiphlogistine Rub A-535 Capsaicin
Axsain
Bio-0615
BPBio1_001053
BRD-K37056290-001-01-1
BRD-K50590187-001-06-6
BRN 2816484
BSPBio_000957
BSPBio_001548
BSPBio_002917
C06866
C-1700
C18H27NO3
Capsaicin
CAPSAICIN (2444-46-4 NONIVAMIDE (SYNTHETIC CAPSAICIN))
Capsaicin (in oleoresin of capsicum)
Capsaicin (JAN/USP)
Capsaicin (Natural)
Capsaicin [in oleoresin of capsicum]
Capsaicin [USAN]
Capsaicin Patch
Capsaicina
Capsaicine
CAPSAICINE
Capsicum farmaya
Capsicum Farmaya
Capsidol
Capsin
Capzasin
Carter horner brand OF capsaicin
Carter Horner Brand of Capsaicin
Caswell No. 158
CCRIS 1588
Centrum brand OF capsaicin
Centrum Brand of Capsaicin
CHEBI:3374
CHEMBL294199
CID1548943
D002211
D00250
depletes Substance P
e-Capsaicin
E-CAPSAICIN
EINECS 206-969-8
Elan brand OF capsaicin
Elan Brand of Capsaicin
EPA Pesticide Chemical Code 070701
epsilon-Capsaicin
FEMA No. 3404
Flemming brand OF capsaicin
Flemming Brand of Capsaicin
FT-0082538
Gelcen
|
HMS1361N10
HMS1570P19
HMS1791N10
HMS1921H11
HMS1989N10
HMS2089N11
HMS2092D21
HMS501B16
HSDB 954
I01-2469
IDI1_000354
IDI1_034018
Isodecenoate
Isodecenoate vanillylamide
Isodecenoic acid
Isodecenoic acid vanillylamide
Katrum
Link brand OF capsaicin
Link Brand of Capsaicin
LS-2138
M1149
M2028_SIGMA
Medicis brand OF capsaicin
Medicis Brand of Capsaicin
MEGxp0_001448
MLS002154049
MolPort-001-742-263
MR3H3
n-(4-hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide
N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide
N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
N-[(4-hydroxy-3-methoxy-phenyl)methyl]nonanamide
NCGC00090853-01
NCGC00090853-02
NCGC00090853-03
NCGC00090853-04
NCGC00090853-06
NCGC00090853-07
NCGC00090853-08
NCGC00090853-09
nchembio.146-comp1
nchembio862-comp2
NCI-C56564
neurotoxic
NGX 4010
NGX-1998
NGX-3781
NGX4010
NGX-4010
NGX-7325
NSC 56353
NSC56353
Prestwick_204
Prestwick2_000879
Prestwick3_000879
Qutenza
S1990_Selleck
SDCCGMLS-0066678.P001
Smaller brand OF capsaicin
Smaller Brand of Capsaicin
SMP2_000337
SMR000718774
SPECTRUM1501128
Spectrum5_000538
Styptysat
Thompson brand OF capsaicin
Thompson Brand of Capsaicin
TL8002946
TQ-1018
trans-8-Methyl-N-vanillyl-6-nonenamide
Transacin
trans-Capsaicin
UNII-S07O44R1ZM
UPCMLD-DP092
UPCMLD-DP092:001
UPCMLD-DP092:002
Vinas brand OF capsaicin
Vinas Brand of Capsaicin
Zacin
ZINC01530575
Zostrix
ZOSTRIX (TN)
Zostrix HP
|
|
3 |
|
Etoricoxib |
Approved, Investigational |
Phase 4 |
|
202409-33-4 |
123619 |
Synonyms:
202409-33-4
5CH
5-chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine
5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine
5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulphonyl)phenyl)pyridine
5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine
5-chloro-3-(4-Methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-chloro-3-(4-Methanesulphonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-Chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-chloro-6'-Methyl-3-(P-(methylsulphonyl)phenyl)-2,3'-bipyridine
5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine
AC1L3WZM
Algix
Arcoxia
C11718
C422649
CHEBI:106706
CHEBI:6339
CHEMBL416146
CID123619
D03710
DB01628
|
DB07166
Etoricoxib
étoricoxib
Etoricoxib (USAN/INN)
Etoricoxib [USAN:INN:BAN]
Etoricoxibe
Etoricoxibum
FT-0082494
HMS2090A05
L001141
L791456
L-791456
LS-181802
Merck Sharp & Dohme brand of etoricoxib
MK 0663
MK 663
MK-0663
MK-663
MolPort-003-847-339
NCGC00164578-01
Nucoxia
Tauxib
UNII-WRX4NFY03R
ZINC00579472
|
|
4 |
|
Budesonide |
Approved |
Phase 4 |
|
51333-22-3 |
63006 5281004 |
Synonyms:
(11b,16a)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11β,16α)-16,17-(butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11β,16α)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
AC-4697
B 7777
B7777_SIGMA
Bidien
Bio-0010
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Budecort Inhaler
Budenofalk
Budeson
Budesónida
budesonide
Budesonide
Budesonide (JAN/USAN/INN)
Budesonide [USAN:INN:BAN:JAN]
Budesonide Easyhaler
Budesonide MMX
Budesonide, (R)-isomer
Budesonide, (S)-isomer
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
Cortivent
CPD000058337
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
Entocort
Entocort EC
Entocort EC (TN)
EU-0100174
Giona Easyhaler
HMS1569H17
|
HMS1921I22
HMS2094I13
HMS501H17
Horacort
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
Lopac0_000174
LS-187734
LS-7235
MAP-0010
Micronyl
Miflonide
MLS000028507
MLS001077323
MLS002207112
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick_840
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort turbuhaler
Pulmicort Turbuhaler
Respules
Rhinocort
Rhinocort alpha
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S1286_Selleck
S-1320
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
ST51039033
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Unit dose budesonide
ZINC03938751
ZINC04097286
|
|
5 |
|
Ethanol |
Approved |
Phase 4 |
|
64-17-5 |
702 |
Synonyms:
(C6-C9)Alkyl alcohol
[CH2Me(OH)]
[OEtH]
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
1-Hydroxyethane
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
absolute alcohol
Absolute alcohol
Absolute Alcohol
Absolute ethanol
Absolute Ethanol
Absolute ethyl alcohol
AC1L19TW
AC1Q31MM
Aethanol
Aethanol [German]
Aethylalkohol
AHD 2000
AI3-01706
Alcare hand degermer
Alcare Hand Degermer
alcohol
Alcohol
Alcohol (ethyl)
Alcohol (USP)
Alcohol [USP]
ALCOHOL 5% IN D5-W
Alcohol anhydrous
Alcohol Anhydrous
Alcohol dehydrated
Alcohol denatured
alcohol etilico
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Absolute
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, Dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, Diluted
Alcohol, ethyl
Alcohol, grain
Alcohol, Grain
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool ethylique
Alcool Ethylique
Alcool éthylique
Alcool etilico
Alcool Etilico
Algrain
Alkohol
Alkohol [German]
Alkoholu etylowego
Alkoholu Etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
bmse000297
C00469
C2H5OH
C2H6O
Caswell No. 426
Caswell No. 430
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
|
CHEMBL545
CID702
Colamine
Cologne spirit
Cologne Spirit
Cologne spirits
D000431
D00068
DB00898
Dehydrated alcohol
Dehydrated ethanol
Dehydrated Ethanol
Denatured alcohol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Denatured Ethanol
Desinfektol el
Desinfektol EL
Diluted alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
Envision Conditioner Pdd 9020
EOH
EOX
Esumiru WK 88
ETA
etanol
Etanol
Etanolo
Etanolo [Italian]
ethanol
éthanol
Ethanol (9CI)
Ethanol [JAN]
Ethanol 200 proof
Ethanol 200 Proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol Vapor
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl alc
ethyl alcohol
Ethyl alcohol
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl Alcohol Anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl Hydrate
Ethyl hydroxide
Ethyl Hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
EtOH
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
grain alcohol
Grain alcohol
Hinetoless
HSDB 531
HSDB 82
Hydroxyethane
HYDROXYETHYL GROUP
I14-12648
IMS 99
Infinity pure
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated spirit
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
MolPort-001-785-844
NCGC00091458-01
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
potato Alcohol
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spirits OF wine
spiritus vini
Spiritus vini
Spirt
SY Fresh M
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
UNII-3K9958V90M
USAF EK-1597
WLN: Q2
|
|
6 |
|
leucovorin |
Approved |
Phase 4 |
|
58-05-9 |
6006 143 |
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-formyltetrahydrofolate
5-Formyltetrahydrofolate
5-formyltetrahydrofolic acid
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formylTHF
Acid, folinic
Acide folinique
Acido folinico
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
Citrovorum factor
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
|
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monosodium salt
Leucovorinum
Leukovorin
Leukovorum
Levoleucovorin
L-leucovorin
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Rescuvolin
Welcovorin
Wellcovorin
|
|
7 |
|
Interferon beta-1b |
Approved |
Phase 4 |
|
145155-23-3 |
|
Synonyms:
Betaseron
Fibroblast interferon
IFN-beta
Interferon beta 1b (recombinant)
|
Interferon beta precursor
Interferon beta-1b,recombinant
Interferon-beta-1b
Recombinant interferon beta-1b
|
|
8 |
|
Interferon beta-1a |
Approved, Investigational |
Phase 4 |
|
145258-61-3 |
6438354 |
Synonyms:
145258-61-3
Avonex
Avonex (TN)
Belerofon
D04554
Fibroblast interferon
IFN-beta
Interferon beta 1a
Interferon beta 1-a
|
Interferon beta precursor
Interferon beta-1a
Interferon beta-1a (genetical recombination)
Interferon beta-1a (genetical recombination) (JAN)
Interferon beta-1a (recombinant human)
Interferon beta-1a (USAN)
Interferon beta-1a,recombinant
Interferon-beta-1a
|
|
9 |
|
Pregabalin |
Approved, Investigational |
Phase 4 |
|
148553-50-8 |
5486971 |
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(R-)-3-Isobutyl gaba
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S)-3-Isobutyl GABA
(S+)-3-isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3 Isobutyl gaba
3-(Aminomethyl)-5-methylhexanoic acid
3-isobutyl GABA
3-Isobutyl gaba
3-Isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
|
CI-1008
CID5486971
D02716
DB00230
FT-0080911
GABA, 3-isobutyl
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregabalina
Pregablin
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
|
|
10 |
|
Bupivacaine |
Approved, Investigational |
Phase 4 |
|
2180-92-9, 38396-39-3 |
2474 |
Synonyms:
( inverted exclamation markA)-bupivacaine
(+-)-Bupivacaine
(±)-bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(RS)-bupivacaine
15233-43-9
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
2180-92-9
38396-39-3
AB00053674
Abbott brand OF bupivacaine hydrochloride
AC1L1DRE
AC1Q5LX4
AC-2096
AH 250
AKOS001637202
Anekain
Anhydrous, bupivacaine
AR-1A0242
Astra brand OF bupivacaine hydrochloride
AstraZeneca brand OF bupivacaine hydrochloride
Aventis brand OF bupivacaine hydrochloride
Bio-0886
Bloqueina
BPBio1_000298
Braun brand OF bupivacaine hydrochloride
Braun, bupivacaina
BRD-A01636364-003-05-2
BSPBio_000270
BSPBio_002607
Bucaine
Bucaine (TN)
Bupivacain janapharm
Bupivacain RPR
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaina braun
bupivacaine
Bupivacaine
Bupivacaine (INN)
Bupivacaine [INN:BAN]
Bupivacaine anhydrous
Bupivacaine carbonate
Bupivacaine Carbonate
Bupivacaine HCL
Bupivacaine HCL kit
Bupivacaine HCL KIT
Bupivacaine hydrochloride
Bupivacaine monohydrochloride, monohydrate
Bupivacaine Monohydrochloride, Monohydrate
Bupivacain-RPR
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
Buvacaina
C07529
C18H28N2O
Carbonate, bupivacaine
Carbostesin
cBupivacaine
CBupivacaine
CHEBI:3215
|
CHEMBL1098
CID2474
D07552
DB00297
DepoBupivacaine
DivK1c_000758
dl-1-Butyl-2',6'-pipecoloxylidide
DL-Bupivacaine
Dolanaest
DUR-843
EINECS 218-553-3
EINECS 253-911-2
HMS2090F12
Hydrochloride, bupivacaine
IDI1_000758
Inibsa brand OF bupivacaine hydrochloride
Janapharm, bupivacain
Jenapharm brand OF bupivacaine hydrochloride
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
KBioGR_001516
KBioSS_002004
KST-1A4609
L000695
LAC-43
LS-109841
LS-2222
Marcain
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
MLS001361336
MolPort-004-955-820
NCGC00178579-01
NCGC00178579-02
NINDS_000758
NSC119660
Pisa brand OF bupivacaine hydrochloride
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
Racemic bupivacaine
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
SMR000058218
SPBio_001558
SPBio_002489
Spectrum_001524
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
Strathmann brand OF bupivacaine hydrochloride
Svedocain sin vasoconstr
Transdur-Bupivacaine
UNII-Y8335394RO
Win 11318
Win 11318 HCl
|
|
11 |
|
Tofacitinib |
Approved, Investigational |
Phase 4 |
|
477600-75-2 |
|
Synonyms:
|
12 |
|
Vedolizumab |
Approved |
Phase 4 |
|
943609-66-3 |
|
13 |
|
Certolizumab pegol |
Approved |
Phase 4 |
|
428863-50-7 |
|
Synonyms:
428863-50-7
CDP870
Certolizumab pegol
Certolizumab pegol (genetical recombination)
|
Certolizumab pegol (genetical recombination) (JAN)
Certolizumab pegol (USAN/INN)
cimzia
D03441
|
|
14 |
|
Mercaptopurine |
Approved |
Phase 4 |
|
50-44-2 |
667490 |
Synonyms:
1,7-dihydro-6H-Purine-6-thione
1,7-Dihydro-6H-purine-6-thione
1,9-dihydro-6H-purine-6-thione
3,7-dihydropurine-6-thione
39454-94-9
3H-Purine-6-thiol
50-44-2
5759-99-9
5818-33-7
5818-60-0
6 Mercaptopurine
6 Mercaptopurine monohydrate
6 Mercaptopurine Monohydrate
6 MP
6 Thiohypoxanthine
6 Thiopurine
6112-76-1
6112-76-1 (monohydrate)
63810_FLUKA
6-Mercaptopurin
6-Mercaptopurine
6-Mercaptopurine monohydrate
6-MERCAPTOPURINE MONOHYDRATE
6-Merkaptopurin
6-Merkaptopurin [Czech]
6-MP
6-Purinethiol
6-Thiohypoxanthine
6-Thiopurine
6-Thioxopurine
7H-purine-6-thiol
7-Mercapto-1,3,4,6-tetrazaindene
9H-Purin-6-yl hydrosulfide
9H-Purine-6(1H)-thione
AC-11464
AC1LDI73
AG-670/31547064
AKOS000170222
AKOS000275858
Ambap50-44-2
BB_SC-0064
BSPBio_001981
BW 57 323H
C01756
C02380
C5H4N4S
CCRIS 2761
CHEBI:2208
CHEBI:50667
CHEMBL1425
CID667490
cMAP_000033
CPD000544948
D015122
D04931
DB01033
DivK1c_000493
EINECS 200-037-4
F3329-0452
FT-0083571
glaxo Wellcome brand OF 6 mercaptopurine
Glaxo Wellcome Brand of 6 Mercaptopurine
glaxo Wellcome brand OF 6-mercaptopurine
Glaxo Wellcome Brand of 6-Mercaptopurine
GlaxoSmithKline brand OF 6 mercaptopurine
GlaxoSmithKline Brand of 6 Mercaptopurine
GlaxoSmithKline brand OF 6-mercaptopurine
GlaxoSmithKline Brand of 6-Mercaptopurine
HMS1920L07
HMS2091B20
HMS501I15
HSDB 3235
I14-1716
IDI1_000493
Ismipur
KBio1_000493
KBio2_001401
KBio2_002363
KBio2_003969
KBio2_004931
KBio2_006537
KBio2_007499
KBio3_001481
|
KBio3_002842
KBioGR_001493
KBioGR_002363
KBioSS_001401
KBioSS_002366
Leukerin
Leukerin, 99% - Carc
Leupu rin
Leupurin
LS-141
M0063
Mercaleukim
Mercaleukin
Mercaptopurin
Mercaptopurin [German]
Mercaptopurina
Mercaptopurina [INN-Spanish]
Mercaptopurina wellcome
Mercaptopurina Wellcome
mercaptopurine
Mercaptopurine
Mercaptopurine (anhydrous)
Mercaptopurine (INN)
Mercaptopurine (VAN)
Mercaptopurine anhydrous
Mercaptopurine monohydrate
Mercaptopurine Monohydrate
Mercaptopurinum
Mercaptopurinum [INN-Latin]
Mercapurin
Merkaptopuryna
Merkaptopuryna [Polish]
Mern
MLS001066623
MLS001304020
MLS001304953
MolPort-001-783-696
MolPort-001-815-626
MolPort-003-846-751
MP
NCGC00094717-01
NCGC00094717-02
NCGC00094717-03
NCI60_041653
NCI-C04886
NCIMech_000025
NINDS_000493
NSC 755
NSC755
NSC-755
PM6
Puri nethol
Puri Nethol
Purimethol
purine antimetabolite: inhibits nucleic acid replication
Purine-6(1H)-thione
Purine-6-thiol
Purinethiol
Purinethol
Puri-nethol
Puri-Nethol
Purinethol (TN)
Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine
S1305_Selleck
SAM002589937
SMR000544948
SPBio_000219
Spectrum_000921
SPECTRUM1500387
Spectrum2_000060
Spectrum3_000491
Spectrum4_000857
Spectrum5_000950
STK727062
Thiopurine
U-4748
UNII-PKK6MUZ20G
Wellcome brand OF 6 mercaptopurine
Wellcome Brand of 6 Mercaptopurine
Wellcome brand OF 6-mercaptopurine
Wellcome Brand of 6-Mercaptopurine
WLN: T56 BM DN FN HNJ ISH
Xaluprine
|
|
15 |
|
Infliximab |
Approved |
Phase 4 |
|
170277-31-3 |
|
Synonyms:
Ig gamma-1 chain C region
Infliximab (genetical recombination)
Infliximab-abda
Infliximab-axxq
|
Infliximab-dyyb
Infliximab-qbtx
Remicade
|
|
16 |
|
Azathioprine |
Approved |
Phase 4 |
|
446-86-6 |
2265 |
Synonyms:
[Methyl(nitroimidazolyl)mercaptopurine]
446-86-6
55774-33-9 (hydrochloride salt)
6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine
6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine
6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine
6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech]
6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine
6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine
6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine
6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine
6-(Methyl-p-nitro-5-imidazolyl)thiopurine
6-(Methyl-p-nitro-5-imidazolyl)-thiopurine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine
6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine
6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine
6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine
A 4638
A2593_SIAL
A4638_SIAL
A4638_SIGMA
AB00443544
AB00443544-03
AC1L1DAL
AC1Q3Z1F
AC-4230
AI3-50290
AI-981/34845012
Azamun
Azamun [Czech]
Azanin
Azasan
Azasan (TN)
Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine
Azathioprin
azathioprine
Azathioprine
Azathioprine (JP15/USP/INN)
Azathioprine [USAN:INN:BAN:JAN]
Azathioprine sodium
Azathioprine Sodium
Azathioprine sodium salt
Azathioprine sulfate
Azathioprinum
Azathioprinum [INN-Latin]
Azathiopurine
azatiopr in
Azatioprin
Azatioprina
Azatioprina [INN-Spanish]
Azothioprine
B. W. 57-322
BPBio1_000054
BRD-K32821942-001-05-6
BRD-K60324116-001-01-5
BSPBio_000048
BSPBio_001876
BW 57322
BW 57-322
BW-57-322
C06837
C9H7N7O2S
CAS-446-86-6
CBDivE_013132
CCRIS 62
Ccucol
CHEBI:2948
CHEMBL1542
ChemDiv1_002659
CID2265
cMAP_000046
CPD000427366
Cytostatics
D00238
DB00993
DivK1c_000586
|
EINECS 207-175-4
EU-0100027
FT-0083532
HMS1568C10
HMS1920E17
HMS2091K19
HMS501N08
HMS594I19
HSDB 7084
IDI1_000586
Immuran
Imuran
Imuran (TN)
Imurek
Imurel
KBio1_000586
KBio2_000464
KBio2_002427
KBio2_003032
KBio2_004995
KBio2_005600
KBio2_007563
KBio3_001376
KBio3_002906
KBioGR_000646
KBioGR_002427
KBioSS_000464
KBioSS_002433
Lopac0_000027
Lopac-A-4638
LS-123
Methylnitroimidazolylmercaptopurine
MLS001049307
MolPort-000-745-914
MolPort-000-764-262
MolPort-003-665-485
Muran
NCGC00015060-01
NCGC00015060-02
NCGC00015060-04
NCGC00015060-12
NCGC00090836-01
NCGC00090836-02
NCGC00090836-03
NCGC00090836-04
NCGC00090836-05
NCGC00090836-06
NCGC00094593-01
NCGC00094593-02
NCGC00094593-03
NCI-C03474
NINDS_000586
NSC 39084
NSC39084
NSC-39084
Oprea1_375441
Oprea1_533384
Oprea1_633462
Prestwick_41
Prestwick0_000094
Prestwick1_000094
Prestwick2_000094
Prestwick3_000094
S1721_Selleck
SAM002589938
SDCCGMLS-0065415.P001
SMR000427366
Sodium, azathioprine
SPBio_000255
SPBio_001987
Spectrum_000064
SPECTRUM1500133
Spectrum2_000068
Spectrum3_000308
Spectrum4_000243
Spectrum5_000848
STK831906
STOCK1S-20293
STOCK1S-27186
Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl)
UNII-MRK240IY2L
WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW
ZINC04258316
|
|
17 |
|
Adalimumab |
Approved |
Phase 4 |
|
331731-18-1 |
16219006 |
Synonyms:
331731-18-1
Adalimumab
Adalimumab (genetical recombination)
Adalimumab (genetical recombination) (JAN)
Adalimumab (USAN/INN)
adalimumab-adaz
adalimumab-adbm
adalimumab-afzb
|
adalimumab-atto
adalimumab-bwwd
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
|
|
18 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
ácido fólico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
AI3-26387
AKOS000503224
Antianemia factor
Apo-Folic
ARONIS014410
b9, Vitamin
BIDD:ER0563
BIDD:GT0641
BIF0608
bmse000299
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat b activ
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
Facid
Factor U
FOL
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
folic acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
|
Folipac
Folsaeure
Folsan
Folsaure
Folsäure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
Incafolic
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
Liver lactobacillus casei factor
Liver Lactobacillus casei factor
LS-2157
Millafol
Mission prenatal
Mittafol
MLS001304016
MLS001335861
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-Pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
nchembio.108-comp10
Nifolin
Nifolin [Denmark]
NINDS_000494
Novofolacid
Novofolacid [Canada]
N-Pteroyl-L-glutamate
N-pteroyl-L-glutamic acid
N-Pteroyl-L-glutamic acid
NSC 3073
PGA
PGA (VAN)
Prestwick_230
Prestwick3_000627
PteGlu
Pteroylglutamate
Pteroylglutamic acid
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
Serum Folate Level
SMP2_000137
SMR000471860
SPBio_001357
Spectrum_001381
SPECTRUM1502020
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin b9
Vitamin B9
Vitamin Bc
Vitamin BC
Vitamin be
Vitamin Be
Vitamin m
Vitamin M
|
|
19 |
|
Phosphonoacetic Acid |
Experimental |
Phase 4 |
|
4408-78-0 |
546 |
Synonyms:
Acid, phosphonacetic
Acid, phosphonoacetic
Carboxymethanephosphonate
Carboxymethanephosphonic acid
Disodium carboxymethylphosphonate
Disodium phosphonoacetate
Disodium phosphonoacetate monohydrate
Fosfonet
Fosfonet sodium
Fosfonoacetate
|
Fosfonoacetic acid
Lopac-P-6909
PAE
Phosphonacetate
Phosphonacetic acid
Phosphonoacetate, disodium
Phosphonoacetic acid
PPA
Sodium, fosfonet
|
|
20 |
|
Reverse Transcriptase Inhibitors |
|
Phase 4 |
|
|
|
21 |
|
Dermatologic Agents |
|
Phase 4 |
|
|
|
22 |
|
Cyclooxygenase 2 Inhibitors |
|
Phase 4 |
|
|
|
23 |
|
Hormones |
|
Phase 4 |
|
|
|
24 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
25 |
|
Anti-Asthmatic Agents |
|
Phase 4 |
|
|
|
26 |
|
Bronchodilator Agents |
|
Phase 4 |
|
|
|
27 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
28 |
|
Antimetabolites |
|
Phase 4 |
|
|
|
29 |
|
Protein Kinase Inhibitors |
|
Phase 4 |
|
|
|
30 |
|
Vitamin B Complex |
|
Phase 4 |
|
|
|
31 |
|
Folic Acid Antagonists |
|
Phase 4 |
|
|
|
32 |
|
Folate |
|
Phase 4 |
|
|
|
33 |
|
Vitamin B9 |
|
Phase 4 |
|
|
|
34 |
|
Fingolimod Hydrochloride |
|
Phase 4 |
|
|
|
35 |
|
MF59 oil emulsion |
|
Phase 4 |
|
|
|
36 |
|
Interferon-beta |
|
Phase 4 |
|
|
|
37 |
|
(T,G)-A-L |
|
Phase 4 |
|
|
|
38 |
|
interferons |
|
Phase 4 |
|
|
|
39 |
|
Glatiramer Acetate |
|
Phase 4 |
|
147245-92-9 |
3081884 |
Synonyms:
(2S)-2,6-diaminohexanoic acid
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid
(2S)-2-aminopentanedioic acid
(2S)-2-aminopropanoic acid
147245-92-9
AC1MIXQC
acetic acid
Aventis brand of copolymer 1
C089995
CID3081884
COP-1
Copaxone
Copolymer 1
|
Copolymer-1
Glatiramer acetate
Glatiramer acetate [USAN]
L-Glutamic acid peptide with L-alanine, L-lysine and L-tyrosine, acetate (salt)
L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt)
LS-186971
LS-71889
Teva brand of copolymer 1
TV 5010
TV5010
TV-5010
UNII-5M691HL4BO
|
|
40 |
|
Calcium, Dietary |
|
Phase 4 |
|
|
|
41 |
|
calcium channel blockers |
|
Phase 4 |
|
|
|
42 |
|
Anesthetics, Local |
|
Phase 4 |
|
|
|
43 |
|
Janus Kinase Inhibitors |
|
Phase 4 |
|
|
|
44 |
|
Heptavalent Pneumococcal Conjugate Vaccine |
|
Phase 4 |
|
|
|
45 |
|
polysaccharide-K |
|
Phase 4 |
|
|
|
46 |
|
Mesalamine |
|
Phase 4 |
|
89-57-6 |
|
47 |
|
Calcium |
Nutraceutical |
Phase 4 |
|
7440-70-2 |
271 |
Synonyms:
Blood coagulation factor XIII
Ca
Ca(2+)
Ca2+
Calcio
Calcium
Calcium element
CALCIUM ion
Calcium, doubly charged positive ion
Calcium, elemental
Coagulation factor XIII
Elemental calcium
Factor XIII
|
Factor XIII a chain
Factor XIII a-chain
Factor XIII transamidase
Factor XIII, coagulation
Fibrin stabilizing factor
Fibrinase
Kalzium
Laki lorand factor
Laki-lorand factor
Stabilizing factor, fibrin
Transamidase, factor XIII
XIII, coagulation factor
|
|
48 |
|
Methylene blue |
Approved, Investigational |
Phase 3 |
|
61-73-4 |
|
Synonyms:
aniline violet
Azul de metileno
Basic Blue 9
C.I. basic blue 9
Chlorure de méthylthioninium
Cloruro de metiltioninio
Lowacryl blue 9
Methylene blue
Methylene blue anhydrous
Methylenium ceruleum
|
methylthionine chloride
Methylthioninii chloridum
methylthioninium chloride
Methylthioninium chloride
methylthioninium chloride Proveblue
Solvent blue 8
Swiss blue
tetrametylthionine chloride
Urolene Blue
|
|
49 |
|
Triamcinolone |
Approved, Vet_approved |
Phase 2, Phase 3 |
|
124-94-7 |
31307 |
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11b,16a,17a,21-Tetrahydroxy-9a-fluoro-1,4-pregnadiene-3,20-dione
11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9a-fluoro-11b,16a,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9a-fluoro-11b,16a,17a,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9a-fluoro-16a-Hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-fluoro-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-fluoro-11beta,16alpha,17alpha,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-fluoro-16alpha-Hydroxyprednisolone
9alpha-Fluoro-16alpha-hydroxyprednisolone
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-fluoro-11b,16a,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9-fluoro-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC1L1LDH
AC1Q5HJC
AC-2072
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
Bio-0662
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
C21H27FO6
Celeste
CHEMBL1451
CID31307
Cinolone
Cinolone-T
CL 19823
D00385
D014221
DB00620
Delphicort
droxypregna-1,4-diene-3,20-dione
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
ione
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-Ag
Kenacort-AG
Kenalog
Kenalog in Orabase
|
Kenalog-10
Kenalog-40
Kenalog-H
Ledercort
Lopac0_001179
LS-698
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
Nasacort
Nasacort Aq
Nasacort Hfa
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
nchembio.2007.53-comp7
NCI60_000750
NSC 13397
NSC13397
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick_438
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Rodinolone
S1933_Selleck
Sk-Triamcinolone
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
T6376_SIGMA
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Triacet
Triacort
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
triamcinolone
Triamcinolone
Triamcinolone (JP15/USP/INN)
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triam-Tablinen
Triatex
Tricortale
Triderm
Trilone
Tri-Nasal
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
|
|
50 |
|
Remifentanil |
Approved |
Phase 3 |
|
132875-61-7 |
60815 |
Synonyms:
132539-07-2 (mono-hydrochloride)
132875-61-7
1-Piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester
3-(4-methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester
3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester
4-carboxy-4-(n-phenylpropionamido)-1-piperidinepropionic acid dimethyl ester
AC1L1TZ8
AC1Q5ZGR
BIDD:GT0029
C08021
CHEBI:8802
CHEMBL1005
CID60815
D08473
DB00899
DEA No. 9739
GI 87084B
|
GI 87084X
GI87084B
L001266
LS-115982
methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate
MolPort-004-286-006
Remifentanil
REMIFENTANIL
Remifentanil (INN)
Remifentanil [INN:BAN]
Remifentanil hydrochloride
Remifentanil monohydrochloride
Remifentanilo
Remifentanyl
Ultiva
Ultiva (TN)
UNII-P10582JYYK
|
|
Interventional clinical trials:
(show top 50)
(show all 389)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Multi-centered, Randomized Study to Evaluate the Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection Compared to Intravenous Acyclovir in Patients With Herpes Zoster From China |
Unknown status |
NCT02151240 |
Phase 4 |
Foscarnet Sodium;Acyclovir |
2 |
Safety and Immunogenicity of Live Attenuated Herpes Zoster Vaccine in Patients Undergoing Living Donor Kidney Transplantations |
Unknown status |
NCT00940940 |
Phase 4 |
|
3 |
A Pilot Study Using a Randomized Design to Evaluate the Immunologic Efficacy and Safety of ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors |
Unknown status |
NCT02444936 |
Phase 4 |
ZOSTAVAX |
4 |
A Pilot Study to Characterize the Immune Response Induced by a Commercial Varicella Zoster Virus Vaccine in Healthy Adult Females in Nairobi, Kenya. |
Unknown status |
NCT02514018 |
Phase 4 |
|
5 |
Phase 4 Study of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination |
Unknown status |
NCT01866566 |
Phase 4 |
|
6 |
Phase 4 Study of the Varicella Vaccine After the 2nd Dose Vaccination |
Unknown status |
NCT01830283 |
Phase 4 |
|
7 |
Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine |
Unknown status |
NCT02146469 |
Phase 4 |
|
8 |
An Enriched Enrollment, Double-Blind, Placebo-Controlled, Parallel Group, Randomized Withdrawal Trial to Evaluate the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Moderate to Severe Neuropathic Pain |
Unknown status |
NCT01264237 |
Phase 4 |
Etoricoxib;Placebo |
9 |
The Role of Qutenza (Topical Capsaicin 8%) in Treating Neuropathic Pain From Critical Ischaemia in Patients With End-stage Renal Failure |
Unknown status |
NCT01704339 |
Phase 4 |
QUTENZA |
10 |
T Cell Responses to Varicella Zoster Virus After Vaccination and Viral Escape |
Completed |
NCT01911065 |
Phase 4 |
|
11 |
Immune Response to Shingles Vaccination |
Completed |
NCT02624375 |
Phase 4 |
Zoster Vaccine Live |
12 |
A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster |
Completed |
NCT02152800 |
Phase 4 |
valacyclovir hydrocholoride |
13 |
Analgetic Effectiveness of Acupuncture When Compared to a Standardised Analgesic Regimen in the Treatment of Herpes Zoster Neuralgia |
Completed |
NCT00885586 |
Phase 4 |
gabapentine |
14 |
An Open-label, Single-arm, Multi-center, Phase IV Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX™ in Healthy Adults in Korea |
Completed |
NCT01556451 |
Phase 4 |
|
15 |
A Phase IV Clinical Trial to Evaluate the Safety and Tolerability of ZOSTAVAX™ in Subjects ≥ 60 Years of Age |
Completed |
NCT00550745 |
Phase 4 |
|
16 |
Immunogenicity and Safety of a Herpes Zoster Vaccine (Zostavax) in Patients With Systemic Lupus Erythematosus: a Randomized Controlled Trial |
Completed |
NCT02477150 |
Phase 4 |
|
17 |
An Open-label, Single-arm, Phase IV Study Assessing the Immunogenicity and Safety of ZOSTAVAX® at Minimum Release Specification Approaching Expiry Potency in Subjects ≥50 Years Old. |
Completed |
NCT00681031 |
Phase 4 |
|
18 |
Palatability Testing of a New Paediatric Formulation of Valacyclovir for the Prophylaxis and Treatment of VZV and HSV Infections in Children |
Completed |
NCT01682109 |
Phase 4 |
Valacyclovir |
19 |
Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™ |
Completed |
NCT02958345 |
Phase 4 |
|
20 |
Rates of Seroconversion Following Varicella Vaccination of Asthmatic Children Between the Ages of One and Eight Years Treated With Pulmicort Respules® Versus Non-Steroidal Conventional Asthma Therapy |
Completed |
NCT00641446 |
Phase 4 |
budesonide;varicella zoster virus |
21 |
The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children |
Completed |
NCT01138215 |
Phase 4 |
|
22 |
A Double-blind, Randomised, Controlled, Multi-centre Safety Study of a Refrigerator-stable Formulation of VARIVAX® in Healthy 12 to 15 Month-old Infants. |
Completed |
NCT00432731 |
Phase 4 |
|
23 |
Blinded, Randomised Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Measles-mumps-rubella-varicella Candidate Vaccine When Given to Healthy Children in Their Second Year of Life |
Completed |
NCT00126997 |
Phase 4 |
|
24 |
A Study to Evaluate the Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine |
Completed |
NCT02173899 |
Phase 4 |
|
25 |
Safety of a Second Dose of Biken's Varicella Vaccine Administered at 4 to 6 Years of Age in Healthy Children in Argentina |
Completed |
NCT00830648 |
Phase 4 |
|
26 |
Evaluation of Safety and Immunogenicity Receiving Live Attenuated Vaccine Against Varicella Without Gelatin |
Completed |
NCT01684072 |
Phase 4 |
|
27 |
A 17 Week, Investigator-initiated, Single-center, Double-blind, Randomized, Placebo-controlled, Cross-over Trial of Pregabalin in Essential Tremor |
Completed |
NCT00646451 |
Phase 4 |
pregabalin;placebo capsules |
28 |
Live Attenuated Varicella Vaccine: A New Effective Adjuvant Weapon in the Battlefield Against Severe Resistant Psoriasis, a Randomized Controlled Trial |
Completed |
NCT01356004 |
Phase 4 |
live attenuated chicken pox vaccine;saline, efficacy |
29 |
A Phase 3b/4 Randomized Double Blind Study Of 5 Mg Of Tofacitinib With And Without Methotrexate In Comparison To Adalimumab With Methotrexate In Subjects With Moderately To Severely Active Rheumatoid Arthritis |
Completed |
NCT02187055 |
Phase 4 |
Tofacitinib with methotrexate;Tofacitinib without methotrexate |
30 |
Immunogenicity and Safety of MF59-adjuvanted Trivalent Influenza Vaccine (Fluad) and 23-valent Pneumococcal Polysaccharide Vaccine (PPV23) in the Elderly: Single Versus Concomitant Vaccination |
Completed |
NCT02225327 |
Phase 4 |
|
31 |
Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13) and MF59-adjuvanted Influenza Vaccine (Fluad) After Concomitant Vaccination in Adults Aged ≥60 Years |
Completed |
NCT02215863 |
Phase 4 |
|
32 |
A 12-month, Prospective, Randomized, Active-controlled, Open-label Study to Evaluate the Patient Retention of Fingolimod vs. Approved First-line Disease Modifying Therapies in Adults With Relapsing Remitting Multiple Sclerosis (PREFERMS) |
Completed |
NCT01623596 |
Phase 4 |
Fingolimod;Disease Modifying therapy |
33 |
Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus |
Recruiting |
NCT03134196 |
Phase 4 |
Masked Placebo;Masked Oral Valacyclovir |
34 |
Safety and Immunogenicity of Recombinant Glycoprotein E Herpes Zoster Subunit (HZ/su) Vaccine in Renal Transplant Recipients |
Recruiting |
NCT03993717 |
Phase 4 |
|
35 |
Efficacy of Pregabalin for the Treatment of Acute Herpetic Neuralgia and for the Prevention of Post Herpetic Neuralgia- a Randomized Controlled Trial |
Recruiting |
NCT03809702 |
Phase 4 |
Pregabalin;Placebo |
36 |
The Immunogenicity and Efficacy of Subunit Vaccine Against Herpes Zoster in RA Treated With JAK-inhibitors (VACCIMIL-ZOSTER) |
Recruiting |
NCT03886038 |
Phase 4 |
|
37 |
Does Stellate Ganglion Blockade (SGB) in Men Treated for Prostate Cancer Improve Hot Flashes? A Pilot Prospective Cohort Study |
Recruiting |
NCT03796195 |
Phase 4 |
.5% Bupivacaine |
38 |
Safety and Immunogenicity of Non-live, Recombinant Subunit Herpes Zoster Vaccine Before and After Lung Transplantation |
Active, not recruiting |
NCT03493776 |
Phase 4 |
|
39 |
Safety and Tolerability of Herpes Zoster Vaccine in Patients With Rheumatoid Arthritis Immunized Prior to Biologics and Tofacitinib Therapy Initiation |
Active, not recruiting |
NCT03016884 |
Phase 4 |
|
40 |
Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction: A Prospective, Controlled Community Embedded Study With Vaccines With Low Coverage Rates (The Improve ACCESS Study) |
Active, not recruiting |
NCT02868970 |
Phase 4 |
|
41 |
Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine in HIV-exposed and HIV-unexposed South African Children |
Active, not recruiting |
NCT03330171 |
Phase 4 |
|
42 |
VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination |
Not yet recruiting |
NCT04403139 |
Phase 4 |
Shingrix |
43 |
A Cross-over, Open-label, Single-group Study to Evaluate the Safety and Immunogenicity of Live Attenuated Varicella Vaccine Skyvaricella Injection (Inj.) Developed by SK Bioscience (Company Limited) Co., Ltd of South Korea in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old |
Not yet recruiting |
NCT04384016 |
Phase 4 |
|
44 |
Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine |
Not yet recruiting |
NCT02026089 |
Phase 4 |
|
45 |
A Pilot Study Evaluating Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab |
Suspended |
NCT03798691 |
Phase 4 |
|
46 |
The Immunogenicity and Safety of Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib |
Suspended |
NCT03591770 |
Phase 4 |
|
47 |
A Double Blind Placebo-controlled Randomized Study of Varicella Zoster Vaccine in Patients With Moderate-to-severe Plaque Psoriasis Who Are Candidates for Biologic Therapy |
Terminated |
NCT02408159 |
Phase 4 |
Varicella Zoster Vaccine;Placebo |
48 |
A Multi-center, Randomized, Double-blinded, Phase 3 Trial to Evaluate the Efficacy Against Herpes Zoster of a Live Attenuated Varicella-Zoster Virus Vaccine in Adults Over 40 Years of Age |
Unknown status |
NCT03314103 |
Phase 3 |
|
49 |
A Comparative Study of Tzanck Smear With Methylene Blue Versus Giemsa Stain to Diagnose Herpes Simplex, Herpes Zoster and Varicella Zoster Skin Infections |
Unknown status |
NCT03178747 |
Phase 3 |
|
50 |
Safety and Immunogenicity of Live Attenuated Oka/Merck Varicella Vaccine in Children Listed to Undergo Solid Organ Transplantation |
Unknown status |
NCT00213304 |
Phase 3 |
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Acyclovir
Acyclovir Sodium
CAPSACIAN PWDR
Capsaicin
CAPSAICIN PWDR
Capsicum extract
|
CAPSICUM OLEORESIN
famciclovir
Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
valacyclovir
Valacyclovir hydrochloride
|
Cochrane evidence based reviews: herpes zoster
|